CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer
Article Details
Authors (27)
Yu Wang
Chao Liu
Song Gao
Bo Wang
Hongwei Wang
School of Physics and Laboratory of Zhongyuan Light
Zijian Shi
Shunjin Xia
Jiayong Li
Xiaofeng Yao
Xiaofan Guo
Department of Neurology and Neurosurgery, UPMC Stroke Institute, University of Pittsburgh School of Medicine, Pittsburgh
Jianwei Zheng
School of Metallurgy
Qianqian Zhou
The Center for Cancer Research, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine
Zhiqiang Chen
Lei Zheng
Qiang Zhang
Jiang Du
Tianxing Zhou
Zhaoyu Zhang
Interdisciplinary Materials Research Center, School of Materials Science and Engineering
Weijie Song
Lisha Qi
Yalei Wang
Yuh-Pyng Sher
Min Li
Xuan Zhou
State Key Laboratory of Agricultural and Forestry Biosecurity, Key Laboratory of Ministry of Education for Genetics, Breeding and Multiple Utilization of Crops, Plant Immunity Center, Fujian Agriculture and Forestry University
Mien-Chie Hung
Yu Ren
Department of Medicine, The University of Oklahoma Health Sciences Center
Jihui Hao